Researchers refined a DNA base-editing technology to make it more precise. Cystic fibrosis can result from more than 1,000 different mutations, and many genetic diseases need very specific therapies. A common problem for base editors is unintended "bystander" mutations when nearby DNA letters are changed by accident.
The team modified the molecular linker between the editor parts and weakened how strongly the editor binds to DNA. In human cell tests the redesigned editor dramatically reduced bystander edits. The most accurate variant lowered bystander mutations by more than 80% while keeping strong activity at the intended site. At several cystic fibrosis-related sites, unintended edits fell from about 50–60% to under 1% while largely preserving the desired correction.
The work is at an early preclinical stage. More precise editors could help create accurate cell models, test drugs and support more personalised genetic medicine.
Difficult words
- base-editing — a method to change DNA letters directly
- mutation — a change in the DNA sequencemutations
- bystander — a nearby unintended change in DNA
- linker — a small molecule connecting two protein parts
- bind — to attach to DNA or another moleculebinds
- variant — a different form or version of something
- preclinical — before tests in humans begin
- personalised — designed to match one person's needs
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could more precise editors help patients with diseases that have many different mutations?
- Why is it useful to create accurate cell models when testing new drugs?
- What concerns or benefits would you expect from genetic medicine at an early preclinical stage?
Related articles
Vitamin D may slow diabetes for some people
A new analysis of a large US trial suggests vitamin D supplements might delay progression from prediabetes to type 2 diabetes for people with certain vitamin D receptor gene variations. Researchers warn against taking high doses without medical advice.
Lower mGlu5 receptor found across autistic adult brains
A study in The American Journal of Psychiatry found lower availability of a glutamate receptor called mGlu5 across the brains of autistic adults. Researchers used PET, MRI and EEG and say the result could affect future diagnosis and treatment.